Looks to me like everything is moving along as planned and that the trials will get underway in the coming months. Well done Acadia and Neuren.
For those holders that are comfortable waiting on the outcomes of the science, where I imagine the true value of Neuren share price will be reflected, then let’s continue to be patient.
For those who want to turn quick profits or have heart attacks about daily price movement then please feel free to continue to amuse the forum at the various theories for trading patterns.
Best of luck with the trials, let’s hope the science wins out for everyone
Ann: Update on trofinetide Phase 3 trial in Rett syndrome, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$16.48 |
Change
-0.290(1.73%) |
Mkt cap ! $2.076B | |||
| Open | High | Low | Value | Volume |
| $16.58 | $16.74 | $16.40 | $9.107M | 549.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 864 | $16.43 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.50 | 1668 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2025 (20 minute delay) ? |
| NEU (ASX) Chart |